FOLD - Amicus Therapeutics, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Philadelphia,
United States
Type: Equity
FOLD price evolution
FOLD
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $246.99 | $263.32 | $211.31 | $160.6 |
| Short term investments | $39.21 | $16.98 | $54.32 | $106.51 |
| Net receivables | $87.63 | $73.33 | $63.72 | $68.18 |
| Inventory | $59.7 | $56.94 | $51.38 | $27 |
| Total current assets | $483.06 | $463.26 | $432.82 | $399.7 |
| Long term investments | ||||
| Property, plant & equipment | $57.98 | $60.58 | $58.28 | $59.89 |
| Goodwill & intangible assets | $218.29 | $219.12 | $219.94 | $220.76 |
| Total noncurrent assets | $294.82 | $300.83 | $297.27 | $300.82 |
| Total investments | $39.21 | $16.98 | $54.32 | $106.51 |
| Total assets | $777.88 | $764.08 | $730.09 | $700.52 |
| Current liabilities | ||||
| Accounts payable | $15.12 | $23.15 | $26.53 | $37.63 |
| Deferred revenue | ||||
| Short long term debt | $8.32 | $7.76 | $7.84 | $8.01 |
| Total current liabilities | $167.69 | $169.45 | $159.24 | $138.38 |
| Long term debt | $436.74 | $446.52 | $444.33 | $444.01 |
| Total noncurrent liabilities | $450.02 | $461.39 | $459.28 | $459.56 |
| Total debt | $445.06 | $454.29 | $452.17 | $452.01 |
| Total liabilities | $617.71 | $630.85 | $618.51 | $597.95 |
| Shareholders' equity | ||||
| Retained earnings | -$2684.07 | -$2650.23 | -$2628.65 | -$2585.42 |
| Other shareholder equity | $5.24 | -$6.77 | $4.16 | -$6.74 |
| Total shareholder equity | $160.17 | $133.24 | $111.58 | $102.57 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $246.99 | $148.81 | $245.2 | $163.24 |
| Short term investments | $39.21 | $144.78 | $237.3 | $320.03 |
| Net receivables | $87.63 | $66.2 | $52.67 | $46.92 |
| Inventory | $59.7 | $23.82 | $26.82 | $19.56 |
| Total current assets | $483.06 | $423.82 | $596.83 | $579.47 |
| Long term investments | ||||
| Property, plant & equipment | $57.98 | $60.31 | $63.08 | $67.16 |
| Goodwill & intangible assets | $218.29 | $197.8 | $197.8 | $197.8 |
| Total noncurrent assets | $294.82 | $300.35 | $308.31 | $307.05 |
| Total investments | $39.21 | $144.78 | $237.3 | $320.03 |
| Total assets | $777.88 | $724.17 | $905.14 | $886.52 |
| Current liabilities | ||||
| Accounts payable | $15.12 | $15.41 | $41.85 | $42.89 |
| Deferred revenue | ||||
| Short long term debt | $8.32 | $8.55 | $7.41 | $6.87 |
| Total current liabilities | $167.69 | $139.02 | $145.97 | $129.68 |
| Long term debt | $436.74 | $391.99 | $432.72 | $434.86 |
| Total noncurrent liabilities | $450.02 | $462.1 | $451.8 | $470.46 |
| Total debt | $445.06 | $452.12 | $440.13 | $441.73 |
| Total liabilities | $617.71 | $601.12 | $597.77 | $600.14 |
| Shareholders' equity | ||||
| Retained earnings | -$2684.07 | -$2532.41 | -$2295.92 | -$2045.46 |
| Other shareholder equity | $5.24 | -$11.99 | $4.98 | $8.23 |
| Total shareholder equity | $160.17 | $123.05 | $307.37 | $286.38 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $115.08 | $103.5 | $94.5 | $86.27 |
| Cost of revenue | $11.32 | $9.95 | $9.11 | $6.94 |
| Gross Profit | $103.76 | $93.56 | $85.39 | $79.33 |
| Operating activities | ||||
| Research & development | $35.03 | $40.7 | $35.15 | $41.5 |
| Selling, general & administrative | $70.24 | $65.65 | $65.42 | $73.96 |
| Total operating expenses | $107.45 | $108.58 | $103.91 | $116.71 |
| Operating income | -$3.69 | -$15.03 | -$18.52 | -$37.38 |
| Income from continuing operations | ||||
| EBIT | -$18.83 | -$11.72 | -$28.02 | -$41.38 |
| Income tax expense | $2.18 | -$3.13 | $2.71 | -$0.29 |
| Interest expense | $12.83 | $12.99 | $12.49 | $11.84 |
| Net income | ||||
| Net income | -$33.84 | -$21.58 | -$43.23 | -$52.93 |
| Income (for common shares) | -$33.84 | -$21.58 | -$43.23 | -$52.93 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $399.36 | $329.23 | $305.51 | $260.89 |
| Cost of revenue | $37.33 | $38.6 | $34.47 | $31.04 |
| Gross Profit | $362.03 | $290.63 | $271.05 | $229.84 |
| Operating activities | ||||
| Research & development | $152.38 | $276.68 | $272.05 | $308.44 |
| Selling, general & administrative | $275.27 | $213.04 | $192.71 | $156.41 |
| Total operating expenses | $436.66 | $501.68 | $470.97 | $473.7 |
| Operating income | -$74.63 | -$211.04 | -$199.92 | -$243.85 |
| Income from continuing operations | ||||
| EBIT | -$99.95 | -$204.92 | -$209.08 | -$251.83 |
| Income tax expense | $1.48 | -$5.47 | $8.91 | $2.6 |
| Interest expense | $50.15 | $37.12 | $32.47 | $22.43 |
| Net income | ||||
| Net income | -$151.58 | -$236.57 | -$250.46 | -$276.85 |
| Income (for common shares) | -$151.58 | -$236.57 | -$250.46 | -$276.85 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$33.84 | -$21.58 | -$43.23 | -$52.93 |
| Operating activities | ||||
| Depreciation | $2.18 | $2.23 | $2.21 | $1.26 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $18.09 | $16.51 | $16.58 | $34.89 |
| Total cash flows from operations | $3.46 | -$38.35 | -$16.13 | -$18.07 |
| Investing activities | ||||
| Capital expenditures | -$1.73 | -$1.56 | -$2.2 | -$1.94 |
| Investments | -$22.23 | $37.33 | $52.2 | $38.2 |
| Total cash flows from investing | -$23.96 | $35.77 | $50 | $36.26 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $32.24 | $40 | $38.77 | -$7.8 |
| Net borrowings | -$20.88 | -$0.03 | -$0.02 | -$0.03 |
| Total cash flows from financing | $8.21 | $37.62 | $23.67 | -$7.83 |
| Effect of exchange rate | -$3.91 | $16.9 | -$8.19 | $1.51 |
| Change in cash and equivalents | -$16.2 | $51.94 | $49.35 | $11.87 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$151.58 | -$236.57 | -$250.46 | -$276.85 |
| Operating activities | ||||
| Depreciation | $7.87 | $5.34 | $6.21 | $8.85 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $86.08 | $76.51 | $57.84 | $49.15 |
| Total cash flows from operations | -$69.09 | -$166.57 | -$202.49 | -$233.29 |
| Investing activities | ||||
| Capital expenditures | -$7.44 | -$0.35 | -$3.88 | -$3.23 |
| Investments | $105.5 | $92.67 | $82.64 | -$10.35 |
| Total cash flows from investing | $98.06 | $92.32 | $78.76 | -$13.58 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $103.21 | -$7.18 | $229.21 | $32.25 |
| Net borrowings | -$20.96 | -$0.28 | -$0.48 | $230.6 |
| Total cash flows from financing | $61.68 | -$7.46 | $212.07 | $262.86 |
| Effect of exchange rate | $6.31 | -$14.62 | -$5.05 | $3.83 |
| Change in cash and equivalents | $96.96 | -$96.34 | $83.29 | $19.82 |
News
Fundamentals
| Market cap | $2.71B |
|---|---|
| Enterprise value | $2.91B |
| Shares outstanding | 293.59M |
| Revenue | $399.36M |
|---|---|
| EBITDA | -$92.08M |
| EBIT | -$99.95M |
| Net Income | -$151.58M |
| Revenue Q/Q | 30.63% |
| Revenue Y/Y | 21.30% |
| P/E ratio | -17.88 |
|---|---|
| EV/Sales | 7.28 |
| EV/EBITDA | -31.58 |
| EV/EBIT | -29.09 |
| P/S ratio | 6.79 |
| P/B ratio | 17.49 |
| Book/Share | 0.53 |
| Cash/Share | 0.84 |
| EPS | -$0.52 |
|---|---|
| ROA | -20.40% |
| ROE | -119.46% |
| Debt/Equity | 3.86 |
|---|---|
| Net debt/EBITDA | -4.03 |
| Current ratio | 2.88 |
| Quick ratio | 2.52 |